JPRN-UMIN000034509已完成未知
Feasibility and efficacy of FOLFIRINOX therapy in patients with borderline resectable pancreatic cancer in the neoadjvant setting. - Feasibility and efficacy of FOLFIRINOX therapy in patients with borderline resectable pancreatic cancer in the neoadjvant setting
Department of Hepatobiliary Pancreatic Surgery, Saitama Medical Center, Saitama Medical University0 个研究点目标入组 30 人开始时间: 2018年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Chemotherapy naiive for pancreatic cancer 2) Active double cancer 3) Active infection 4) HBs antigen positive 5) patients are using flucytosine, phenytoin, warfarin 6) pregnant females, possibly pregnant females
研究者
相似试验
尚未招募
2 期
Converison therapy of FOLFIRINOX in patients with unresectable locally advanced pancreatic cancer: A phase IInresectable locally advanced pancreatic cancerJPRN-UMIN000014039Yokohama City University50
已完成
不适用
Observational study of FOLFIRINOX therapy for unresectable and recurrence pancreatic cancerunresectable and recurrence pancreatic cancerJPRN-UMIN000014658Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC)329
招募中
2 期
eoadjuvant FOLFIRINOXPancreatic cancer, Neoadjuvant therapyPancreatic cancerJPRN-jRCT1041220027Yamashita Tatsuya50
招募中
3 期
eoadjuvant chemotherapy in resectable pancreatic cancerCancer - PancreaticPancreatic cancerACTRN12624000005550Epworth HealthCare100
尚未招募
Unknown
Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer: an international multicenter randomized controlled trialKCT0008360Seoul National University Hospital609